Skip to main content
You are now leaving this website.
Are you sure?
NO
YES
SEARCH IN KEDRION
Start typing...
kedrion biopharma
Kedrion Corporate
Kedrion S.p.A
Kedrion International GmbH
Kedrion Biopharma GmbH
Kedrion Biopharma - Russia
HUMAN Bioplazma Kft
Kedrion Mexicana S.A.
Kedrion Portugal Lda.
Kedrion Biopharma - Switzerland
KEDPLASMA USA
RhoGAM
Koate
Gammaked
Albuked
KEDRAB
social network
LinkedIn
About us
Corporate Structure
Annual Report
Corporate Social Responsibility
Environment, Health & Safety
Supporting our people
Support to communities
Expertise
Activities
Medical & Scientific Information
Product Development
Quality & Safety
Therapies
Therapeutic areas
Hematology/Hemophilia
Immunology/Neurology
Critical care
Business Partners
Services
Italian partnership
Contract manufacturing
Technology transfer
Biological Safety Center
Plasma
Donors
News
Contact
Pharmacovigilance
Careers
Open Menu
About us
About us
Corporate Structure
Annual Report
Corporate Social Responsibility
Corporate Social Responsibility
Environment, Health & Safety
Supporting our people
Support to communities
Expertise
Expertise
Activities
Medical & Scientific Information
Product Development
Quality & Safety
Therapies
Therapies
Therapeutic areas
Therapeutic areas
Hematology/Hemophilia
Immunology/Neurology
Critical care
Business Partners
Services
Services
Italian partnership
Contract manufacturing
Technology transfer
Biological Safety Center
Plasma
Donors
News
Contact
Contact
Pharmacovigilance
Careers
social network
LinkedIn official page
kedrion biopharma
Kedrion Corporate
Kedrion S.p.A
Kedrion International GmbH
Kedrion Biopharma GmbH
Kedrion Biopharma - Russia
HUMAN Bioplazma Kft
Kedrion Mexicana S.A.
Kedrion Portugal Lda.
Kedrion Biopharma - Switzerland
KEDPLASMA USA
RhoGAM
Koate
Gammaked
Albuked
KEDRAB
all
CORPORATE
EVENTS
PLASMA & BIOTHERAPIES
R&D
2021
2006
2007
2008
2009
2010
2011
2012
2013
2015
2016
2017
2018
2020
2021
News
CORPORATE
- 04-01-2021
Kedrion Biopharma Phase III Trial, CARES10, achieves important milestone: Last Patient Treated
Last Patient Treated
read more
For more information please contact:
[email protected]